Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.

ABSTRACT:

Importance

Local-level data are needed to understand whether the relaxation of X-waiver training requirements for prescribing buprenorphine in April 2021 translated to increased buprenorphine treatment.

Objective

To assess whether relaxation of X-waiver training requirements was associated with changes in the number of clinicians waivered to and who prescribe buprenorphine for opioid use disorder and the number of patients receiving treatment.

Design, setting, and participants

This serial cross-sectional study uses an interrupted time series analysis of 2020-2022 data from the HEALing Communities Study (HCS), a cluster-randomized, wait-list-controlled trial. Urban and rural communities in 4 states (Kentucky, Massachusetts, New York, and Ohio) with a high burden of opi

SUBMITTER: Christine PJ 

PROVIDER: S-EPMC11301557 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature